| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
4,141 |
528 |
$126K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
11,559 |
652 |
$50K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
5,456 |
505 |
$6K |
| 83970 |
|
405 |
371 |
$3K |
| J1756 |
Injection, iron sucrose, 1 mg |
984 |
288 |
$2K |
| A4657 |
Syringe, with or without needle, each |
1,547 |
731 |
$2K |
| 83540 |
|
359 |
337 |
$0.00 |
| 85048 |
|
511 |
478 |
$0.00 |
| 85041 |
|
507 |
475 |
$0.00 |
| 82108 |
|
43 |
41 |
$0.00 |
| 83550 |
|
360 |
337 |
$0.00 |
| 82728 |
|
314 |
291 |
$0.00 |
| 82306 |
|
82 |
81 |
$0.00 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
31 |
29 |
$0.00 |